Physical Activity in Patients With Systemic Lupus Erythematosus
NCT ID: NCT00985803
Last Updated: 2009-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
60 participants
INTERVENTIONAL
2009-11-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Randomized controlled blinded trial, 63 patients aged 42.9 ± 14.4 and diagnosis of systemic lupus erythematosus (SLE) according to the criteria of the College American Rheumatology, 1997. After randomization patients were allocated into 3 groups, control group (CG) (n = 21), training cardiovascular (CT) (n = 20), resistance training (RT) (n = 22), performing 12 weeks of intervention with a frequency of three times weeks and were evaluated at two different times (T0 and T12). As primary outcome quality of life was assessed by the inventory Generic Assessment of quality of life by the Medical Outcomes Study 36 -- Healthy ItemShort Form Survey (SF36) and as secondary outcomes functional capacity evaluation of pain symptoms (visual scale analogue pain \[VAS\]), intensity of symptoms of depression (Beck Depression Inventory \[BDI\]), index of disease activity (Systemic Lupus Disease Activity Inventory Erythmatodud \[SLEDAI\]), capacity aerobic (walking test of 12 minutes \[T12\]), subjective perception effort (subjective scale of Borg \[Borg\]), limb muscle strength lower (analog dynamometer \[strength\]), electrical activity member lower (surface electromyography \[EMG\]), amount of products (inventory amount of Medicines).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Lupus Erythematosus Exercise Program
NCT03942718
Exercise and Systemic Lupus Erythematosus
NCT01515163
Motivating Individuals With Lupus to Exercise
NCT05287581
Aerobic Exercise in Women With Systemic Lupus Erythematosus
NCT03186794
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After screening, patients will read and sign the informed consent form. The study will be submitted to the ethics committee of the Federal University of São Paulo / Escola Paulista de Medicina.
Randomization will be done by a secretary using a computer program specifically for this purpose, where the groups will be divided into intervention and control. The random allocation will be maintained using opaque sealed envelopes, which will open at the time of intervention.
Control group will not perform any type of training. Since the experimental group will be divided into two groups, cardio training (CT) and endurance exercise training (ET).
Evaluation will be conducted at the beginning and end of 12 weeks by two raters blind (who will not know to which groups, individuals were allocated) that will use the following tools:
* Outcomes
* Assessment of pain
* Assessment of pain before and after training, the visual analog scale of pain, ranging from 0 (zero) no pain and 10 cm (ten) 14 unbearable pain
Evaluation of the depression:
Evaluation of the depression at the beginning and end of the proposed training, inventory Beck Depression Inventory. (BDI). This inventory of multiple choice will be used to measure the severity of depression. These include symptoms of depression, irritability, cognitive impairment, guilt, feelings of being punished, physical symptoms such as fatigue, weight loss, lack of interest in sex.
Assessment of quality of life:
Generic Assessment of quality of life by the SF 36 (Short From 36), beginning and end of the proposed treatment. Validated in Portuguese in 1999 (Ciconelli et al, 1999). It consists of eight domains (physical functioning, limitation in physical appearance, bodily pain, general health, vitality, social, emotional, and mental health ranging from 0 (zero) to 100 (one hundred), and the higher the note is better quality of life.
Activity disease:
Activity Level by Systemic Lupus Erythematosus Disease Activity Inventory (SLEDAI) at the beginning and end of the proposed treatment.
Aerobic Capacity:
Cooper test of walking and / or running in 12 minutes. Only for the experimental group of aerobic training, aiming to prescribe the training range cardiovascular.O test aims to measure the aerobic capacity of subjects. The test results will be classified as "VERY GOOD", "GOOD", "MIDDLE", "BAD", "very poor", which will be based on distance traveled, age and sex of the individual being evaluated.
Muscle strength:
Evaluation of muscle strength through a load cell placed in a leg extension to 60 degrees of extension.
Activity Muscle:
Assessment of quadriceps muscle activation using electromyography
The experimental group of cardiovascular training will hold a training still between 55% to 65% of maximum heart rate ..
The experimental group of resistance training will carry out the training with 8 years of training session with 12 reps with that load will vary according to the 1 RM test.
The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Control
No interventions assigned to this group
Endurance
Physical Activity: Endurance exercise training (ET)
The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.
The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Cardiovascular
Physical Activity: Cardio training (CT)
The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.
The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Activity: Cardio training (CT)
The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.
The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Physical Activity: Endurance exercise training (ET)
The experimental group of resistance training will carry out the training with 8 kinds of training session with 12 reps with that load will vary according to the 1 RM test.
The composition of the training session is 10 minutes of heating and stretching, 40 minutes of cardiovascular training and 10 minutes of cooling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* malar erythema
* discoid lesions
* photosensitivity
* oral or nasal ulcers
* arthritis
* serositis
* renal
* neurological
* hematological
* immunological changes
* antinuclear antibodies.
Exclusion Criteria
* Bronchitis, asthma, emphysema)
* Heart failure (NYHA\> II)
* History of myocardial ischemia or heart
* Blood pressure\> 100 mm Hg.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federal University of São Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo I Abrahão
Role: PRINCIPAL_INVESTIGATOR
University Federal of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AmbulatoAmbulatory Specialty Interlagos - General Hospital Grajaú - Association Congregation Santa Catarina
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAbrahao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.